Holmusk is a provider of healthcare data and technology solutions to support the treatment of mental health and chronic diseases.
Holmusk has raised $30.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2023.
Holmusk's investors include Novartis, Optum Ventures, Veradigm, Health Catalyst Capital, Heritas Capital.
Holmusk is headquartered in Singapore, Singapore.
Holmusk is a provider of healthcare data and technology solutions to support the treatment of mental health and chronic diseases.
Holmusk is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Holmusk — Funding & Investors." VCBacked, October 12, 2023, https://www.vcbacked.co/company/holmusk. Accessed July 21, 2026.
VCBacked. (2023). Holmusk — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/holmusk
{{cite web |title=Holmusk — Funding & Investors |url=https://www.vcbacked.co/company/holmusk |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated